|
121 |
Prognostic four-gene signature for overall survival in patients with hepatocellular carcinoma
Enthalten in Hepatology international Bd. 13, 16.8.2019, Nr. 5, date:9.2019: 519-520
|
|
|
|
122 |
Prolonged hepatitis caused by cytomegalovirus and non-alcoholic steatohepatitis in 16-year-old obese boy
Enthalten in Zeitschrift für Kinderheilkunde Bd. 164, 29.1.2005, Nr. 4, date:4.2005: 212-215
|
|
|
|
123 |
Randomized controlled study of gemcitabine plus S-1 combination chemotherapy versus gemcitabine for unresectable pancreatic cancer
Enthalten in Cancer chemotherapy and pharmacology Bd. 73, 10.12.2013, Nr. 2, date:2.2014: 389-396
|
|
|
|
124 |
Response to peginterferon-alpha 2b and ribavirin in Japanese patients with chronic hepatitis C genotype 1
Enthalten in Hepatology international Bd. 7, 10.2.2012, Nr. 1, date:3.2013: 144-152
|
|
|
|
125 |
Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents
Enthalten in BMC gastroenterology Bd. 14, 3.10.2014, Nr. 1, date:12.2014: 1-9
|
|
|
|
126 |
Role of contrast-enhanced ultrasonography with Sonazoid for hepatocellular carcinoma: evidence from a 10-year experience
Enthalten in Journal of gastroenterology Bd. 51, 22.12.2015, Nr. 5, date:5.2016: 421-433
|
|
|
|
127 |
Safe recovery of a fully fractured basket in the bile duct using endoscopic papillary large balloon dilation
Enthalten in Endoscopy Bd. 46, 2014, Nr. S 01, 01: E365-E366
|
|
|
|
128 |
Safety and tolerance of sorafenib in Japanese patients with advanced hepatocellular carcinoma
Enthalten in Hepatology international Bd. 5, 22.1.2011, Nr. 3, date:9.2011: 850-856
|
|
|
|
129 |
Sorafenib treatment in Child–Pugh A and B patients with advanced hepatocellular carcinoma: safety, efficacy and prognostic factors
Enthalten in Investigational new drugs Bd. 33, 12.4.2015, Nr. 3, date:6.2015: 729-739
|
|
|
|
130 |
Subgroup analysis of efficacy and safety of orantinib in combination with TACE in Japanese HCC patients in a randomized phase III trial (ORIENTAL)
Enthalten in Medical oncology Bd. 36, 3.5.2019, Nr. 6, date:6.2019: 1-11
|
|
Administration
